The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway

The identification of cancer-associated mutations in the tricarboxylic acid (TCA) cycle enzymes isocitrate dehydrogenases 1 and 2 (IDH1/2) highlights the prevailing notion that aberrant metabolic function can contribute to carcinogenesis. IDH1/2 normally catalyse the oxidative decarboxylation of iso...

Полное описание

Библиографические подробности
Главные авторы:	Carbonneau, M, M Gagné, L, Lalonde, M, Germain, M, Motorina, A, Guiot, M, Secco, B, Vincent, E, Tumber, A, Hulea, L, Bergeman, J, Oppermann, U, Jones, R, Laplante, M, Topisirovic, I, Petrecca, K, Huot, M, Mallette, F
Формат:	Journal article
Язык:	English
Опубликовано:	Springer Nature 2016

Схожие документы

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
по: Mélissa Carbonneau, и др.
Опубликовано: (2016-09-01)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases.
по: Chowdhury, R, и др.
Опубликовано: (2011)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
по: Chowdhury, R, и др.
Опубликовано: (2011)

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
по: Chowdhury, R, и др.
Опубликовано: (2011)

Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
по: Teng, Xin, и др.
Опубликовано: (2016)

Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
по: Mengyuan Cai, и др.
Опубликовано: (2024-01-01)

Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate
по: Lorenzo Galluzzi, и др.
Опубликовано: (2018-12-01)

Focused screening identifies different sensitivities of human TET oxygenases to the oncometabolite 2-hydroxyglutarate
по: Belle, R, и др.
Опубликовано: (2024)

The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
по: Vivek A. Hariharan, и др.
Опубликовано: (2017-03-01)

mTOR as a central regulator of lifespan and aging [version 1; peer review: 3 approved]
по: David Papadopoli, и др.
Опубликовано: (2019-07-01)

Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
по: Brad Evans, и др.
Опубликовано: (2015-07-01)

Oncometabolites D- and L-2-hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions
по: Chen, Fangyi, и др.
Опубликовано: (2018)

Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents
по: Pu Wang, и др.
Опубликовано: (2015-12-01)

Oncometabolite D-2-hydroxyglutarate—dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia
по: Xinting Zhu, и др.
Опубликовано: (2023-09-01)

The oncometabolite R-2-hydroxyglutarate dysregulates the differentiation of human mesenchymal stromal cells via inducing DNA hypermethylation
по: Lizhen Liu, и др.
Опубликовано: (2021-01-01)

Intracerebral Distribution of the Oncometabolite D-2-Hydroxyglutarate in Mice Bearing Mutant Isocitrate Dehydrogenase Brain Tumors: Implications for Tumorigenesis
по: Amanda Pickard, и др.
Опубликовано: (2016-10-01)

mTOR Signaling in Growth Control and Disease
по: Laplante, Mathieu, и др.
Опубликовано: (2014)

Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation
по: Mary Taub, и др.
Опубликовано: (2022-09-01)

Oncometabolite D-2-Hydroxyglutarate enhances gene silencing through inhibition of specific H3K36 histone demethylases
по: Ryan Janke, и др.
Опубликовано: (2017-03-01)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
по: Luyan Mu, и др.
Опубликовано: (2018-03-01)

Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
по: Zoltán Hujber, и др.
Опубликовано: (2017-06-01)

Accumulation of oncometabolite D-2-Hydroxyglutarate by SLC25A1 inhibition: A metabolic strategy for induction of HR-ness and radiosensitivity
по: Kexu Xiang, и др.
Опубликовано: (2022-07-01)

An emerging role of mTOR in lipid biosynthesis
по: Laplante, Mathieu, и др.
Опубликовано: (2012)

The emerging role of fumarate as an oncometabolite.
по: Yang, M, и др.
Опубликовано: (2012)

Oncometabolites: linking altered metabolism with cancer.
по: Yang, M, и др.
Опубликовано: (2013)

Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
по: Luyuan Li, и др.
Опубликовано: (2015-01-01)

The Emerging Role of LPA as an Oncometabolite
по: Theodoros Karalis, и др.
Опубликовано: (2024-04-01)

The emerging role of fumarate as an oncometabolite
по: Ming eYang, и др.
Опубликовано: (2012-07-01)

Kynurenine: an oncometabolite in colon cancer
по: Niranjan Venkateswaran, и др.
Опубликовано: (2020-01-01)

Hydroxyglutaric Acidemia
по: J Gordon Millichap
Опубликовано: (1992-09-01)

Oncometabolites: A new insight for oncology
по: Fatemeh Khatami, и др.
Опубликовано: (2019-09-01)

Targeting mTOR in Acute Lymphoblastic Leukemia
по: Carolina Simioni, и др.
Опубликовано: (2019-02-01)

Autism and Hydroxyglutaric Aciduria
по: J Gordon Millichap
Опубликовано: (2008-04-01)

The Roles of 2-Hydroxyglutarate
по: Xin Du, и др.
Опубликовано: (2021-03-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
по: Zhilin Zou, и др.
Опубликовано: (2020-03-01)

DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
по: Peterson, Timothy R., и др.
Опубликовано: (2015)

The mTOR–lysosome axis at the centre of ageing
по: Julian M. Carosi, и др.
Опубликовано: (2022-04-01)

AAA + ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1
по: George K. E. Umanah, и др.
Опубликовано: (2022-08-01)

Oncometabolite induced primary cilia loss in pheochromocytoma
по: O'Toole, SM, и др.
Опубликовано: (2019)

Dietary protein sources differentially affect microbiota, mTOR activity and transcription of mTOR signaling pathways in the small intestine.
по: Soumya K Kar, и др.
Опубликовано: (2017-01-01)